- Home
- ZVSA vs FRGT Comparison
ZVSA vs FRGT Comparison
Compare ZVSA & FRGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- FRGT
- Stock Information
- Founded
- ZVSA 2014
- FRGT 2015
- Country
- ZVSA United States
- FRGT United States
- Employees
- ZVSA N/A
- FRGT N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- FRGT Professional Services
- Sector
- ZVSA Health Care
- FRGT Consumer Discretionary
- Exchange
- ZVSA Nasdaq
- FRGT Nasdaq
- Market Cap
- ZVSA 2.5M
- FRGT 2.9M
- IPO Year
- ZVSA N/A
- FRGT N/A
- Fundamental
- Price
- ZVSA $1.10
- FRGT $1.59
- Analyst Decision
- ZVSA Strong Buy
- FRGT
- Analyst Count
- ZVSA 1
- FRGT 0
- Target Price
- ZVSA $240.00
- FRGT N/A
- AVG Volume (30 Days)
- ZVSA 243.8K
- FRGT 181.7K
- Earning Date
- ZVSA 11-14-2024
- FRGT 12-31-2024
- Dividend Yield
- ZVSA N/A
- FRGT N/A
- EPS Growth
- ZVSA N/A
- FRGT N/A
- EPS
- ZVSA N/A
- FRGT N/A
- Revenue
- ZVSA N/A
- FRGT $17,060,753.00
- Revenue This Year
- ZVSA N/A
- FRGT $144.53
- Revenue Next Year
- ZVSA N/A
- FRGT $55.01
- P/E Ratio
- ZVSA N/A
- FRGT N/A
- Revenue Growth
- ZVSA N/A
- FRGT N/A
- 52 Week Low
- ZVSA $0.98
- FRGT $1.30
- 52 Week High
- ZVSA $25.00
- FRGT $99.75
- Technical
- Relative Strength Index (RSI)
- ZVSA 41.83
- FRGT 49.16
- Support Level
- ZVSA $0.99
- FRGT $1.45
- Resistance Level
- ZVSA $1.20
- FRGT $1.70
- Average True Range (ATR)
- ZVSA 0.08
- FRGT 0.16
- MACD
- ZVSA 0.04
- FRGT 0.03
- Stochastic Oscillator
- ZVSA 54.55
- FRGT 58.41
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.